Volume 54, Issue 5, Pages (May 2011)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 67, Issue 3, Pages (September 2017)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Inflammasomes in liver diseases
Chronic Kidney Disease in Diabetes
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
by Clarisse Toledo, George Thomas, Jesse D
Volume 68, Issue 5, Pages (May 2018)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Uric Acid as a Target of Therapy in CKD
Non-invasive diagnosis of non-alcoholic fatty liver disease
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Nat. Rev. Nephrol. doi: /nrneph
Living donor liver transplantation: is the hype over?
Jason T. Lee, MD, Vinit N. Varu, MD, Kenneth Tran, BS, Ronald L
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Mesenchymal stromal cell therapy for liver diseases
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Volume 58, Issue 3, Pages (March 2013)
Cardiovascular Disease and CKD: Core Curriculum 2010
European Association for the Study of the Liver  Journal of Hepatology 
John P. Middleton, Patrick H. Pun  Kidney International 
Abstracts from Around the World
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Trends in the management and burden of alcoholic liver disease
Volume 61, Issue 3, Pages (September 2014)
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Your Kidneys May Outlive You
Volume 62, Issue 3, Pages (March 2015)
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Genomic risk of hepatitis C-related hepatocellular carcinoma
When the journey from obesity to cirrhosis takes an early start
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual 
Socioeconomic Status and Reduced Kidney Function in the Whitehall II Study: Role of Obesity and Metabolic Syndrome  Talal M. Al-Qaoud, MD, MSc, Dorothea.
The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver diseasePowell EE, Cooksley WGE, Hanson R, Searle J,
Volume 69, Issue 5, Pages (November 2018)
AGA technical review on nonalcoholic fatty liver disease
Immunosuppression in liver transplant recipients with renal impairment
Volume 67, Issue 3, Pages (September 2017)
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Drug Dose Adjustments in Patients With Renal Impairment
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Methods for guideline development
The use of hemospray in portal hypertensive bleeding; a case series
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
A 360-degree overview of paediatric NAFLD: Recent insights
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Volume 75, Issue 1, Pages (January 2009)
Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)
The metabolomic window into hepatobiliary disease
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Volume 54, Issue 5, Pages 1020-1029 (May 2011) Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?  Giovanni Targher, Michel Chonchol, Giacomo Zoppini, Cataldo Abaterusso, Enzo Bonora  Journal of Hepatology  Volume 54, Issue 5, Pages 1020-1029 (May 2011) DOI: 10.1016/j.jhep.2010.11.007 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Adjusted means (±standard deviations) of estimated glomerular filtration rate (GFR) in relation to the histologic severity of non-alcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from zero to three) in patients with NASH. p value for the trend is determined by means of analysis of covariance. Data have been adjusted for age, sex, body mass index, waist circumference, hypertension status, levels of triglycerides, and insulin resistance (as estimated by homeostasis model assessment). Data are from Targher et al. [34]. Journal of Hepatology 2011 54, 1020-1029DOI: (10.1016/j.jhep.2010.11.007) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Schematic representation of potentially causative mechanisms by which NAFLD may contribute to the development and progression of chronic kidney disease. Journal of Hepatology 2011 54, 1020-1029DOI: (10.1016/j.jhep.2010.11.007) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions